Publications 2017-08-08T19:34:56+00:00


  1. Jarosinski, K.W. Interindividual spread of herpesviruses 2017. In: Cell Biology of Herpes Viruses, Adv Anat Embryol Cell Biol. 223:195-224. PM: 28528445
  2. Buckingham, E., W. Jarosinski, W. Jackson, J.E. Carpenter, and C. Grose. 2016. Exocytosis of varicella-zoster virions involves a convergence of endosomal and autophagy pathways. J Virol. 90(19):8673-8685. PM: 27440906
  3. *Jarosinski, K.W. and J.F. Vautherot. 2015. Differential expression of Marek’s disease virus (MDV) late proteins during in vitro and in situ replication: Role for pUL47 in regulation of the MDV UL46-UL49 gene locus. Virology 484:213-226. PM: 26117307
  4. *Jarosinski, K.W., K.M. Donovan, and G. Du. 2015. Expression of fluorescent proteins within the repeat long region of the Marek’s disease virus genome allows direct identification of infected cells while retaining full pathogenicity. Virus Res. 201:50-60. PM: 25725150
  5. Schippers, T., W. Jarosinski, and N. Osterrieder. 2015. The ORF012 gene of Marek’s disease virus (MDV) 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth. J Virol. 89(2):1348-1363. PM: 25392220
  6. Shaikh, S.L., U. Katneni, H. Dong, S. Gaddamanugu, P. Tavlarides-Hontz, W. Jarosinski, N. Osterrieder, and M.S. Parcells. 2013. A deletion in the glycoprotein L (gL) gene of U.S. Marek’s disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B. Avian Dis. 57(2 Suppl):509-518. PM: 23901769
  7. Schat, K.A., M.S. Piepenbrink, E.L. Buckles, Ynte H. Schukken, and W. Jarosinski. 2013. Importance of differential expression of Marek’s disease virus gene pp38 for the pathogenesis of Marek’s disease. Avian Dis. 57(2 Suppl):503-508. PM: 23901768
  8. *Veiga, I., W. Jarosinski, B.B. Kaufer, and N. Osterrieder. 2013. Marek’s disease virus (MDV) ubiquitin-specific protease (USP) performs critical functions beyond its enzymatic activity during virus replication. Virology 437(2):110-117. PM: 23399034
  9. *Jarosinski, K.W. Marek’s disease virus late protein expression in feather follicle epithelial cells as early as 8 days post-infection. Avian Dis. 56(4):725-731. PM: 23397845
  10. *Jarosinski, K.W. and N. Osterrieder. 2012. Marek’s disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission. J Virol. 86(15):7896-7906. PM:22593168
  11. *Jarosinski, K.W. Dual infection and superinfection inhibition of epithelial skin cells by two alphaherpesviruses co-occur in the natural host. PLoS ONE. 7(5):e37428. PM: 22629393
  12. *Jarosinski, K.W., S. Arndt, B.B. Kaufer, and N. Osterrieder. 2012. Fluorescently tagged pUL47 of Marek’s disease virus reveals differential tissue expression of the tegument protein in vivo. J Virol. 86(6):2428-2436. PM:22190714
  13. *Kaufer, B.B., S. Arndt, S. Trapp, N. Osterrieder, and W. Jarosinski. 2011. Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis. PLoS Pathog. 7(10):e1002333. PM:22046133
  14. Kaufer, B.B., W. Jarosinski, and N. Osterrieder. 2011. Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation. J Exp Med. 208(3):605-615. PM:21383055
  15. Kaufer, B.B., S. Trapp, W. Jarosinski, and N. Osterrieder. 2010. Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT). PLoS Pathog. 6(8):e1001073. PM:20865127
  16. *Jarosinski, K.W., H.D. Hunt, and N. Osterrieder. 2010. Down-regulation of MHC class I by the Marek’s disease virus (MDV) UL5 gene product mildly affects virulence in a haplotype-specific fashion. Virology. 405(2):457-463. PM:20637486
  17. *Jarosinski, K.W. and N. Osterrieder. 2010. Further analysis of Marek’s disease virus horizontal transmission confirms UL44 (gC) and UL13 protein kinase activity are essential, while US2 is non-essential. J Virol. 84(15):7911-7916. PM:20484497
  18. Chbab, N., A. Egerer, I. Veiga, W. Jarosinski, and N. Osterrieder. 2010. Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek’s disease virus (MDV). Vet Res. 41(5):56. PM:20423696
  19. Buscaglia, C., P.H. O’Connell, W. Jarosinski, I. Pevzner, and K.A. Schat. 2009. Selection for increased nitric oxide production does not increase resistance to Marek’s disease in a primary broiler breeder line. Avian Dis. 53(3):336-340. PM:19848069
  20. Fulton, A., S.T. Peters, G.A. Perkins, W. Jarosinski, A. Damiani, M. Brosnahan, E.L. Buckles, N. Osterrieder, and G.R. Van de Walle. 2009. Effective treatment of respiratory alphaherpesvirus infection using RNA interference. PLoS ONE. 4(1):e4118. PM:19122813
  21. Van de Walle, G.R., W. Jarosinski, and N. Osterrieder. 2008. Alphaherpesviruses and chemokines: A pas de deux not yet brought to perfection. J Virol. 82(13):6090-6097. PM:18385255
  22. Miller, M.M., W. Jarosinski, and K.A. Schat. 2008. Negative modulation of the chicken infectious anemia virus promoter by COUP-TF1 and an E box-like element at the transcription start site binding δEF1. J Gen Virol. 89:2998-3003. PM:19008385
  23. Jarosinski, K.W., L.M. Kattenhorn, H. Ploegh, and N. Osterrieder. 2007. A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. Proc Nat Acad Sci USA. 104:20025-20030. PM:18056809
  24. *Jarosinski, K.W., N.G. Margulis, J.P. Kamil, S.J. Spatz, V.K. Nair, and N. Osterrieder. 2007. Horizontal transmission of Marek’s disease virus requires US2, the UL13 protein kinase, and gC. J Virol. 81(19):10575-10587. PM:17634222
  25. *Jarosinski, K.W. and K.A. Schat. 2007. Multiple mRNA splicing to exons II and III of viral interleukin-8 (vIL-8): The importance of vIL-8 exon I. Virus Genes. 34(1):9-22. PM:16927116
  26. *Jarosinski, K.W., B.K. Tischer, S. Trapp, and N. Osterrieder. Marek’s Disease Virus: Lytic Replication, Oncogenesis, and Control. Exp Rev in Vaccines. 5(6):761-772. PM:17184215
  27. Poonia, , P.A. Dunn, H. Lu, K.W. Jarosinski, and K.A. Schat. 2006. Isolation and molecular characterization of a new Muscovy duck parvovirus from Muscovy ducks in the USA. Avian Path. 35(6):435-441. PM:17121731
  28. Li, X.,W. Jarosinski, and K.A. Schat. 2006. Expression of Marek’s disease virus phosphorylated polypeptide pp38 produces splice variants and enhances metabolic activity. Vet Micro. 117:154-168. PM:16876339
  29. Jarosinski, K.W., N. Osterrieder, V.K. Nair, and K.A. Schat. 2005. Attenuation of Marek’s disease virus (MDV) by deleting open reading frame RLORF4, but not RLORF5a. J Virol. 79(18):11647-11659. PM:16140742
  30. Jarosinski, K.W., B.L. Njaa, P.H. O’Connell, and K.A. Schat. 2005. Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek’s disease virus. Viral Immunol. 18(1):149-162. PM:15802959
  31. Miller, M.M., W. Jarosinski, and K.A. Schat. 2005. Positive and negative transcriptional regulation of chicken anemia virus. J Virol. 79(5):2859-2868. PM:15709005
  32. Yunis, R, W. Jarosinski, and K.A. Schat. 2004. Association between rate of viral replication and virulence of Marek’s disease herpesvirus strains. Virol. 328:142-150. PM:15380365
  33. *Jarosinski, K.W., P.H. O’Connell, and K.A. Schat. 2003. Impact of deletions within the BamHI-L fragment of attenuated Marek’s disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4. Virus Genes. 26(3):255-269. PM:12876454
  34. Jarosinski, K.W., R. Yunis, P.H. O’Connell, C.J. Markowski-Grimsrud, and K.A. Schat. 2002. Influence of genetic resistance of the chicken and virulence of Marek’s disease virus (MDV) on nitric oxide responses after MDV infection. Avian Dis. 46:636-649. PM:12243528 (P.P. Levine Award for best paper published in Avian Diseases in 2002)
  35. Jarosinski, K.W. and P.T. Massa. 2002. Interferon regulatory factor-1 is required for interferon-g-induced MHC class I genes in astrocytes. J Neuroimmunol. 122:74-84. PM:11777545
  36. Jarosinski, K.W., W. Jia, M.J. Sekellick, P.I. Marcus, and K.A. Schat. 2001. Cellular responses in chickens treated with IFN-a orally or inoculated with recombinant Marek’s disease virus expressing IFN-a. J Interferon Cytokine Res. 21:287-296. PM:11429159
  37. Jarosinski, K.W., L.W. Whitney, and P.T. Massa. 2001. Specific deficiency in nuclear factor-kB activation in neurons of the central nervous system. Lab Invest. 81(9):1275-1288. PM:11555675
  38. Massa, P.T., S. Saha, C. Wu, and W. Jarosinski. 2000. Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes. Glia. 29:376-285. PM:10652447
  39. Massa, P.T., L.W. Whitney, C. Wu, S.L. Ropka, K.W. Jarosinski. 1999. A mechanism for selective induction of 2’-5’ oligoadenylate synthetase, anti-viral state, but not MHC class I genes by interferon-beta in neurons. J Neurovirol. 5(2):161-71. PM:10321980